Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog? Jeffrey A. TiceMitchell D. Feldman Review 22 March 2007 Pages: 157 - 165
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy David CellaLesley J. Fallowfield Review 18 September 2007 Pages: 167 - 180
Insulin-like growth factor binding proteins and breast cancer Ashok SubramanianAnup SharmaKefah Mokbel Review 05 July 2007 Pages: 181 - 194
SUMO and estrogen receptors in breast cancer Michalis V. KaramouzisPanagiotis A. KonstantinopoulosAthanasios G. Papavassiliou Review 13 March 2007 Pages: 195 - 210
Prophylactic IL-12 treatment reduces postoperative metastasis: mediation by increased numbers but not cytotoxicity of NK cells Yossi SchwartzRoi AvrahamShamgar Ben-Eliyahu Preclinical Study 13 March 2007 Pages: 211 - 223
Exploring the two-gene ratio in breast cancer—independent roles for HOXB13 and IL17BR in prediction of clinical outcome Piiha-Lotta JerevallSara BrommessonOlle Stål Preclinical Study 24 April 2007 Pages: 225 - 234
EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor Clara HwangVeda N. GiriColin S. Duckett Preclinical Study 24 April 2007 Pages: 235 - 242
The spectrum of ATM missense variants and their contribution to contralateral breast cancer Annegien BroeksLinde M. BraafLaura J. Van ‘t Veer Preclinical Study Open access 28 March 2007 Pages: 243 - 248
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases Ashish B. RajputDmitry A. TurbinDavid G. Huntsman Preclinical Study Open access 13 March 2007 Pages: 249 - 257
Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors Rachel E. EllsworthJeffrey A. HookeCraig D. Shriver Preclinical Study 10 March 2007 Pages: 259 - 265
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells Haiming XuDonghong JuYouming Xie Preclinical Study 13 March 2007 Pages: 267 - 274
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer Armelle DufresneXavier PivotAimery De Gramont Clinical Trial 23 March 2007 Pages: 275 - 279
ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? Teresa TapiaAlejandro SanchezPilar Carvallo Epidemiology 10 March 2007 Pages: 281 - 288
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk Claire E. WakefieldBettina Meiserthe AGenDA Collaborative Group Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary 27 February 2007 Pages: 289 - 301
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines Omer DizdarDidem S. DedeKadri Altundag Letter to the Editor 10 March 2007 Pages: 303 - 303
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women Martha L. SlatteryCarol SweeneyTim Byers Erratum 22 May 2007 Pages: 305 - 305
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study Agnés FournierFranco BerrinoFrançoise Clavel-Chapelon Erratum 26 July 2007 Pages: 307 - 308
